Myositis: all 246 studies
Page 1 of 3. Open to participants first (104), then studies with results posted, then the rest; newest registration first within each.
- A Study of BMS-986553 in Participants With Refractory Autoimmune DiseasesNot yet recruitingNCT07873931Phase 1
- Investigation of Type I Interferon Excess in Patients With Systemic Autoimmune Diseases and Genetic Type I InterferonopathiesNot yet recruitingNCT07837986Not applicable
- Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body MyositisRecruitingNCT07823101
- FT839 in Autoimmune DiseasesRecruitingNCT07800871Phase 1/2
- A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory MyopathiesNot yet recruitingNCT07789015Phase 3
- A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune DiseasesNot yet recruitingNCT07782450Phase 1/2
- A Study to Test CRT-402 in Refractory Autoimmune DiseaseRecruitingNCT07778446Phase 1/2
- Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung DiseaseRecruitingNCT07775235
- Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular ResearchNot yet recruitingNCT07737470
- BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory MyopathyRecruitingNCT07715136Phase 1
- Anti-inflammation Treatment for Idiopathic Inflammatory MyopathiesNot yet recruitingNCT07668505Phase 4
- CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune DiseasesNot yet recruitingNCT07596680Early Phase 1
- Muscle Imaging Project Using ANatomopathology and Full Field Optical Coherence TomographyNot yet recruitingNCT07552220
- Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic DiseasesNot yet recruitingNCT07544225Phase 1
- Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.RecruitingNCT07526493Phase 1
- MTS109 in Patients With Refractory Autoimmune DiseasesRecruitingNCT07526350Early Phase 1
- Muscle Health Measurements Using Electrical Impedance MyographyRecruitingNCT07502989
- YTS109 in Pediatric Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT07439029Phase 1
- A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune DiseasesRecruitingNCT07413341Phase 1
- Descartes-08 in Autoantibody MyositisRecruitingNCT07391605Phase 2
- MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)RecruitingNCT07374107
- A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)RecruitingNCT07371468Phase 1
- TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM)Not yet recruitingNCT07355257Phase 2/3
- Tongji NADs CohortNot yet recruitingNCT07333196
- A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)RecruitingNCT07331272Phase 1
- A Study of AZD0120 in Autoimmune DiseasesRecruitingNCT07295847Phase 1
- A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune DiseasesRecruitingNCT07284797Phase 1
- Inspiratory Muscle Training in Patients With Inflammatory MyopathyRecruitingNCT07274267Not applicable
- Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease PatientsRecruitingNCT07249060
- Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune DiseasesRecruitingNCT07236801Phase 1
- An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesRecruitingNCT07236762Phase 1
- OM336 in Seropositive Autoimmune DiseasesRecruitingNCT07229144Phase 1
- Mass Spectrometry-based Immune Profiling in Autoimmune DiseasesEnrolling by invitationNCT07188285
- An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune DiseasesRecruitingNCT07174843Early Phase 1
- Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)RecruitingNCT07160205Phase 2/3
- Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and EfficacyRecruitingNCT07150000
- A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune DiseasesRecruitingNCT07123519Phase 1
- A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune DiseasesRecruitingNCT07115745Phase 1
- A Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesRecruitingNCT07104721Phase 1
- Ublituximab in Autoantibody Positive Immune Mediated Necrotizing MyopathyRecruitingNCT07103746Phase 2
- Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesRecruitingNCT07087912Phase 4
- GC012F Injection in Refractory Idiopathic Inflammatory MyopathyRecruitingNCT07086404Early Phase 1
- Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune DiseasesRecruitingNCT07085676Phase 1
- A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune DiseaseRecruitingNCT07085104Phase 1
- EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular DiseasesRecruitingNCT07077304
- GC012F in Patients With Autoimmune DiseasesNot yet recruitingNCT07072884Early Phase 1
- A Study of KITE-363 in Participants With Refractory Autoimmune DiseasesEnrolling by invitationNCT07038447Phase 1
- Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune DiseasesRecruitingNCT07022197Phase 1/2
- AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.RecruitingNCT06991114Phase 2
- Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAVNot yet recruitingNCT06986018Early Phase 1
- A Study of OL-108 in Relapsed/Refractory Autoimmune DiseasesRecruitingNCT06980597Phase 1
- UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune DiseasesNot yet recruitingNCT06978738Phase 1
- A Clinical Study of YTS109 Cell in R/R Autoimmune DiseasesRecruitingNCT06978647Phase 1
- Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT06970951Early Phase 1
- CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune DiseasesRecruitingNCT06941129Phase 1
- A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune DiseaseRecruitingNCT06925542Phase 1
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.RecruitingNCT06916806Phase 1
- Renal Manifestations During Idiopathic Inflammatory MyopathiesRecruitingNCT06904937
- Safety Study of CC312 in Autoimmune Disease PatientsRecruitingNCT06888960Early Phase 1
- Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune DiseasesRecruitingNCT06828042Phase 1/2
- Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined With Immunosuppressants in the Treatment of Refractory Autoimmune DiseasesNot yet recruitingNCT06821659Phase 1/2
- BCMA-CD19 CAR-T Therapy for Refractory Autoimmune DiseasesRecruitingNCT06794008Phase 2
- Neuromuscular Complications of MEK Inhibitors: a French Case Series and a Systematic Review of the LiteratureNot yet recruitingNCT06740656
- Genetic Determinants of Myocarditis Induced by Immune-checkpoint InhibitorsRecruitingNCT06734689
- A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)RecruitingNCT06733935Phase 1/2
- AYLo - AutoimmunitY and Loss of yRecruitingNCT06696027
- Rare AutoImmune SElf-management Programme DevelopmentRecruitingNCT06642870
- Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune DiseasesRecruitingNCT06614270Not applicable
- ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUSRecruitingNCT06593041
- Investigation of the Validity, Reliability, and Responsiveness of the BETY-BQ in MyositisRecruitingNCT06587724
- Seating Posture and Its Relation to PainNot yet recruitingNCT06579131
- Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune DiseasesRecruitingNCT06548607Early Phase 1
- Biomarkers in Autoimmune Disease of Nervous SystemRecruitingNCT06502015
- Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body MyositisRecruitingNCT06479863Early Phase 1
- The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT06420154Early Phase 1
- Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT06417398Early Phase 1
- An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune DiseaseRecruitingNCT06379646Not applicable
- A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune DiseaseEnrolling by invitationNCT06375993Phase 1
- Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune DiseaseRecruitingNCT06373081Not applicable
- Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune DiseasesRecruitingNCT06361745Not applicable
- Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)RecruitingNCT06350110Phase 1/2
- Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune DiseasesRecruitingNCT06316076Phase 1
- A Phase 1 Study of FT819 in B-cell Mediated Autoimmune DiseaseRecruitingNCT06308978Phase 1
- Clinical Study Cohort of Idiopathic Inflammatory MyositisNot yet recruitingNCT06306547
- Drug Rediscovery for Rare Immune Mediated Inflammatory DiseasesRecruitingNCT06285539Phase 2
- RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory MyopathyRecruitingNCT06154252Phase 2/3
- Evaluation of Antigen-specific T Cells in Patients With Antisynthetase Syndrome and Interstitial Lung DiseaseRecruitingNCT05984394
- Adult Idiopathic Inflammatory Myopathy With Cardiac InjuryNot yet recruitingNCT05982041
- A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory MyopathyEnrolling by invitationNCT05979441Phase 3
- Characterizing Myositis With 68Ga-FAPI PET/CTRecruitingNCT05952531Early Phase 1
- A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]RecruitingNCT05895786Phase 3
- Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune DiseasesEnrolling by invitationNCT05859997Not applicable
- Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory MyopathyRecruitingNCT05833711Phase 2
- Follow-up of Patients With Inflammatory Myopathies Associated With a BiobankRecruitingNCT05454527
- Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe DiseaseRecruitingNCT05272969
- Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune DiseasesRecruitingNCT05251415
- ILD-SARDs Registry and BiorepositoryRecruitingNCT05007340
- Search for Diagnostic and Prognostic Biomarkers in Systemic Sclerosis and Inflammatory MyopathiesRecruitingNCT04917705Not applicable
- Adult Autoimmune Myopathies (MAIA)RecruitingNCT04792931Not applicable
- Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous SystemRecruitingNCT04561557Early Phase 1